{"id":"intranasal-dexmedetomidine-esketamine","safety":{"commonSideEffects":[{"rate":null,"effect":"Sedation"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Dissociation"},{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Tachycardia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Dexmedetomidine selectively binds alpha-2 adrenergic receptors in the central nervous system to produce sedation, analgesia, and anxiolysis. Esketamine is an NMDA receptor antagonist that provides rapid-onset dissociative anesthesia and analgesia. The intranasal formulation allows non-invasive delivery with faster onset than oral routes.","oneSentence":"This combination drug acts as an alpha-2 adrenergic agonist (dexmedetomidine) and an NMDA receptor antagonist (esketamine) delivered intranasally to produce rapid sedation and analgesia.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:49:44.039Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Procedural sedation and analgesia"},{"name":"Acute pain management"}]},"trialDetails":[{"nctId":"NCT07479602","phase":"PHASE4","title":"Intranasal Dexmedetomidine-esketamine Administration and Postoperative Pain in Pediatric Patients","status":"NOT_YET_RECRUITING","sponsor":"Peking University First Hospital","startDate":"2026-04","conditions":"Adenotonsillectomy, Children, Intranasal Administration","enrollment":160},{"nctId":"NCT07324057","phase":"NA","title":"The Effects of Preoperative Intranasal Administration of Dexmedetomidine and Esketamine on Negative Postoperative Behavioral Changes in Children With Autism Spectrum Disorder","status":"NOT_YET_RECRUITING","sponsor":"Sun Fei","startDate":"2026-02-01","conditions":"Autism Spectrum Disorder","enrollment":234},{"nctId":"NCT06853431","phase":"PHASE4","title":"Determination of ED50 and ED95 With Clinical Efficacy of Intranasal Dexmedetomidine Combined With Esketamine for Preoperative Sedation in Pediatric General Anesthesia","status":"RECRUITING","sponsor":"Second Affiliated Hospital of Wenzhou Medical University","startDate":"2025-03-01","conditions":"Preoperative Anxiety, Preoperative Sedation, Children","enrollment":80},{"nctId":"NCT04757675","phase":"EARLY_PHASE1","title":"S-ketamin Premedication in Pediatric EENT Surgery","status":"COMPLETED","sponsor":"Eye & ENT Hospital of Fudan University","startDate":"2021-03-01","conditions":"Emotions, Separation Anxiety, Pain, Procedural","enrollment":320}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Intranasal dexmedetomidine-esketamine","genericName":"Intranasal dexmedetomidine-esketamine","companyName":"Peking University First Hospital","companyId":"peking-university-first-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This combination drug acts as an alpha-2 adrenergic agonist (dexmedetomidine) and an NMDA receptor antagonist (esketamine) delivered intranasally to produce rapid sedation and analgesia. Used for Procedural sedation and analgesia, Acute pain management.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}